News & Articles

The multi-analyte respiratory panel combines Flu A/B and respiratory syncytial virus (RSV) targets with the SARS-CoV-2 target

A RFID tag designed specifically for accurate tracking of pharmaceutical items

Thermo Scientific TSX Series ultra-low temperature freezers reliably preserve stored materials in an environmentally and user-friendly design

The extended calculation engine is designed to make it even simpler to derive the complex final results that a laboratory needs

OncoHost’s AI-Based proteomic profiling platform, PROphet, to serve key role in host response evaluation of late-stage disease patients

The acquisition supports Algorics' commitment to expanding its team of experienced analytical professionals and sustaining its commercial growth

The new Access AMH Advanced aims to provide validated cut-offs for the assessment of ovarian reserve and ovarian response as an aid for women undergoing in vitro fertilization (IVF)

Watch world-leading clinical scientists and healthcare professionals online, June 22-23, to discover the latest tools and techniques advancing COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more

The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples

Explore the latest science and technology advancements in regenerative medicine, COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more

The Simplexa™ SARS-CoV-2 Variants Direct assay aims to enable detection of four mutations associated with virus variants without requiring upfront RNA extraction

The availability of an International Standard (IS) for antibodies facilitates the standardization of SARS-CoV-2 serological methods

Learn how to optimize your biobanking processes for improved biological material quality, security and traceability

The independent study is being led by Southampton University Health Sciences

In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years

UN3373 compliant sample packaging solution

Watch this on-demand webinar to learn about the commercial responsibilities of new in vitro diagnostic regulations

Vaccine, trialed in 450 children, shows favorable safety profile and was well-tolerated

COVID-19 infections fell by 65% percent after a first dose of the Oxford-AstraZeneca or Pfizer-BioNTech vaccines in this large community surveillance study